Drachman David J 4

4 · AtriCure, Inc. · Filed May 10, 2012

Form 4

Period: 2012-05-08

DirectorPresident and CEO

Transactions

Sale
Common Stock
2012-05-08$9.10/sh−18,575$169,033→ 405,106 total
Exercise/Conversion
Common Stock
2012-05-08$1.33/sh+18,575$24,705→ 423,681 total
Exercise/Conversion
Common Stock
2012-05-10$1.33/sh+87,160$115,923→ 492,266 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-09−2,900→ 118,642 total
Exercise: $1.33From: 2003-10-14Exp: 2012-10-14→ Common Stock (2,900 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-10−1,586→ 117,056 total
Exercise: $1.33From: 2003-10-14Exp: 2012-10-14→ Common Stock (1,586 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-10−87,160→ 29,896 total
Exercise: $1.33From: 2003-10-14Exp: 2012-10-14→ Common Stock (87,160 underlying)
Exercise/Conversion
Common Stock
2012-05-09$1.33/sh+2,900$3,857→ 408,006 total
Exercise/Conversion
Common Stock
2012-05-10$1.33/sh+1,586$2,109→ 406,692 total
Sale
Common Stock
2012-05-10$9.04/sh−1,586$14,337→ 405,106 total
Sale
Common Stock
2012-05-09$9.06/sh−2,900$26,274→ 405,106 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-08−18,575→ 121,542 total
Exercise: $1.33From: 2003-10-14Exp: 2012-10-14→ Common Stock (18,575 underlying)

Footnotes (3)

[F1]This transaction was executed in multiple trades at prices ranging from $9.06 to $9.12 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F2]This transaction was executed in multiple trades at prices ranging from $9.01 to $9.05 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]These options were granted on October 14, 2002 and are exercisable cumulatively at a rate of 25% per annum beginning on October 14, 2003 (one year from grant date).

Documents

1 file